 |
Oregon Health & Science University School of Medicine | |
| City: Portland | State: OR | |
|
Links:
Commentary:_01-01-005__Policy_Compliance.pdf _12-70-010__Authorship_Attr...pdf 10-01-015.docx 10-01-020.docx 10-01-030.docx INDIVIDUAL_ACCEPTANCE_OF_GIFTS-10-01-025.docx Policy__Sample_Medications.pdf Policy__Vendor_Representative.pdf This institution has exemplary gifts and samples policies, as well as a strong annual disclosure policy that includes disclosure to patients in some cases. Prior review is also required for consulting relationships. While industry may not select the recipients of scholarships, there are weaker firewalls in place for industry support of on- and off-site education. This institution submitted revised policies for review in 2010. A subsequent reassessment improved specific domain scores but there final grade remains a B.
This institution's evaluation was last updated: 12/06/2010 |
||
| Gifts & Meals |  |
The policy prohibits the receipt of gifts and defines meals as gifts. The prohibition on acceptance of gifts and meals could be strengthened by removing the statement that the policy only applies to individuals who have the authority to make purchasing or prescribing decisions; however, as this covers faculty in the clinical setting, the score remains a 3. |
| Consulting relationships | |
The policy requires prior approval of all consulting relationships, and requires that all consulting relationships be described in a written contract. |
| Industry-funded speaking relationships |  |
Speaking relationships must be disclosed annually, the material presented must be in complete control of the speaker and the honorarium must be modest. |
| Disclosure | |
The policy requires clinicians to disclose financial relationships annually, and when it is determined that a financial relationship may be a conflict of interests by the institution, the clinician must disclose to any relevant patients. |
| Pharmaceutical samples | |
Almost all samples are prohibited from being distributed except for one clinic which does distribute samples to patients. If this clinic stopped accepting and distributing samples this would be a model policy. |
| Purchasing & Formularies | |
Members on P&T committees are required to disclose annually, but are not required to recuse themselves if the leadership feels that the conflict can be managed. A higher score would involve a requirement for recusal. |
| Industry Sales Representatives |  |
Policy allows for some industry representatives to be on campus without an appointment and in patient care areas. |
| On-campus Education | |
All industry support must follow ACCME or AOA guidelines for industry support regardless of whether or not credit is given. |
| Attendance at Industry-Sponsored Lectures & Meetings Off-Campus | |
No policy presented. |
| Industry Support for Scholarships & Funds for Trainees | |
The policy does not allow for industry to choose the recipient of the scholarship or trainee funds. |
| Medical school curriculum | |
Coursework on pharmaceutical marketing and impact on the medical profession occurs in the second year. The goals of the course are to familiarize students with industry marketing strategies and prepare them for interaction with sales representatives. |
| Do the policies specify an oversight mechanism? |  |
Integrity office responsible for implementation and compliance. |
| Are there explicit sanctions for noncompliance? | |
Sanctions for noncompliance are noted in the policy. |
 | |
 | Model policy |
 | Good progress toward model policy |
 | No policy, or policy unlikely to have a substantial effect on behavior |
 | Did not report |
 | Policy not relevant to this institution (e.g., does not make purchasing decisions) |
